Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based Japanese developer, manufacturer, and distributor of medical electronic equipment. Its portfolio covers neurological measurement, cardiac diagnostics, patient monitoring, respiratory support, emergency care, and clinical information systems. The company serves hospitals and other healthcare providers through operations and subsidiaries in Japan, the United States, Europe, and Asia, with products used in more than 120 countries. The brand is particularly associated with electroencephalography and other neurophysiological equipment. Nihon Kohden is described as the world's largest supplier of EEG products, giving it a distinctive position in a specialized part of the medical-device market. Its broader product range includes EEG systems, electromyography equipment, electrocardiographs, patient monitors, invasive and non-invasive ventilators, defibrillators, automated external defibrillators, and clinical information systems. A major technological milestone came from work by company researcher Takuo Aoyagi. In 1972, Aoyagi invented and patented the basic principles of pulse oximetry, a non-invasive method for estimating blood oxygen saturation and monitoring pulse-related information. In 1974, he developed the OLV-5100, identified as the world's first pulse oximeter. Pulse oximetry subsequently became an important patient-safety technology, particularly in anesthesia and critical-care settings. Nihon Kohden's business scope combines hardware development with software, information systems, service, and international distribution. Its products are used across diagnosis, continuous observation, life support, and emergency response rather than being limited to one clinical specialty. The company therefore presents itself as an integrated medical-electronics provider, while its strongest historical association remains neurological measurement and patient monitoring. The available reference material does not provide verified information about its founding year, founder, current executives, ownership structure, financial performance, or official corporate website URL.

Nihon Kohden is a Japanese medical-electronics company headquartered in Tokyo. The available reference identifies it as a manufacturer, developer, and distributor whose products span diagnostic devices, monitoring systems, life-support equipment, emergency-care equipment, and clinical information systems. Rather than operating as a narrowly specialized device maker, the company addresses several connected stages of clinical work: collecting physiological data, observing patients over time, supporting diagnosis, providing emergency intervention, and integrating information into clinical workflows. The company's most clearly documented area of distinction is neurophysiology. Nihon Kohden is described as the world's largest supplier of EEG products. Electroencephalography records electrical activity in the brain and is used in neurological assessment and related clinical applications. The company's product scope also includes electromyography systems, extending its activity into the measurement of neuromuscular function. These technologies form the neurological and physiological-measurement foundation of the brand. Nihon Kohden also produces cardiac and general patient-care equipment. Its listed products include ECG systems for recording the heart's electrical activity and patient monitors for observing vital signs and other physiological parameters. The portfolio further includes invasive and non-invasive ventilators, which support respiratory care, as well as defibrillators and AEDs intended for emergency cardiac intervention. Clinical information systems complement the physical devices by supporting the handling and use of medical information in care settings. One of the company's most important technological contributions came from Takuo Aoyagi, a researcher at Nihon Kohden. In 1972, Aoyagi invented and patented the basic principles of pulse oximetry. The technique enabled non-invasive estimation of blood oxygen saturation and became important to the observation of patients during procedures and in critical-care environments. Two years later, in 1974, Aoyagi developed the OLV-5100, described in the reference material as the world's first pulse oximeter. The technology helped improve patient safety during anesthesia and later became widely associated with routine clinical monitoring. The company expanded its reach beyond Japan through subsidiaries in the United States, Europe, and Asia. Its equipment is reported to be used in more than 120 countries, indicating a substantial international distribution and service footprint. This geographic reach supports a business model that combines product development and manufacturing with distribution and regional operations. The provided material does not establish a verified founding year, founder, ownership structure, financial history, current leadership roster, or detailed chronology of later product generations and corporate decisions. Consequently, those areas are left unspecified rather than inferred. On the evidence available, Nihon Kohden's historical identity is best understood through three linked themes: Japanese medical-electronics development, global supply of physiological and neurological monitoring equipment, and the company's documented contribution to pulse-oximetry technology.

• 1974

  OLV-5100 pulse oximeter developed

  [1]Nihon Kohdenen.wikipedia.org

  Takuo Aoyagi developed the OLV-5100, identified in the reference material as the world's first pulse oximeter. The device contributed to improved patient safety during anesthesia.

• 1972

  Pulse-oximetry principles patented

  [1]Nihon Kohdenen.wikipedia.org

  Nihon Kohden researcher Takuo Aoyagi invented and patented the basic principles of pulse oximetry, establishing a foundation for non-invasive monitoring of blood oxygen saturation.

A Japanese medical-electronics brand focused on clinical measurement, neurological diagnostics, patient monitoring, respiratory and emergency care, and healthcare information systems. Its historical differentiation is its major role in EEG equipment and the development of foundational pulse-oximetry technology.

• Neurological diagnostics

  EEG systems

  Nihon Kohden's EEG systems measure and display electrical activity in the brain for neurological assessment and related clinical use. EEG is the company's most prominent specialist category: the reference material describes Nihon Kohden as the world's largest supplier of EEG products. These systems form a central part of the brand's medical-electronics identity and its neurophysiology portfolio.

• Neuromuscular diagnostics

  EMG measuring systems

  Electromyography systems measure electrical activity associated with muscles and nerves. Within Nihon Kohden's portfolio, EMG equipment extends the company's neurophysiology offering beyond brain-wave measurement and supports clinical investigation of neuromuscular function. Specific models, launch dates, and current product configurations are not provided in the reference material.

• Cardiac diagnostics

  ECG systems

  Nihon Kohden's ECG equipment records the electrical activity of the heart for cardiac assessment. ECG systems complement the company's neurological and general monitoring products by addressing a core diagnostic measurement used in hospitals and other healthcare environments. The available material does not identify individual models or their release chronology.

• Patient monitoring

  Patient monitors

  Patient monitors provide ongoing observation of physiological information in clinical settings. Nihon Kohden lists patient monitoring among its principal medical-electronics businesses, linking measurement hardware with bedside and broader clinical-care workflows. No specific monitor families, technical specifications, or launch years are established by the supplied sources.

• Respiratory care

  Ventilators

  The company supplies both invasive and non-invasive ventilators for respiratory support. This gives Nihon Kohden a role in respiratory and critical-care equipment in addition to its diagnostic and monitoring businesses. The reference material does not provide model names, market launch dates, or detailed clinical indications.

• Emergency and resuscitation equipment

  Defibrillators and AEDs

  Nihon Kohden's emergency-care portfolio includes defibrillators and automated external defibrillators. These devices are intended for electrical intervention during cardiac emergencies and broaden the brand's offering from observation and diagnosis into acute response. Specific product generations and regulatory markets are not stated in the available material.

• Pulse oximetry · 1974

  OLV-5100

  The OLV-5100 was developed by Takuo Aoyagi in 1974 and is identified in the reference material as the world's first pulse oximeter. It embodied the practical application of the pulse-oximetry principles patented two years earlier and helped improve patient safety during anesthesia.

• Healthcare information technology

  Clinical information systems

  Clinical information systems are part of Nihon Kohden's broader healthcare-technology portfolio. They complement the company's medical devices by supporting the management and use of clinical information. The supplied reference does not specify the systems' names, architecture, implementation markets, or release history.

• 2020-04-17

  Toyota and Nihon Kohden work together to boost ventilator production in Japan[2]丰田与日本光电合作提升日本呼吸机产量japantimes.co.jp

  Reported: 2020-04-17

  Toyota Motor and Nihon Kohden are working together to help ramp up ventilator production in Japan. Nihon Kohden said it plans to deliver 1,000 ventilators over the next six months by increasing output fivefold.

1. 1Nihon Kohdenen.wikipedia.org
2. 2丰田与日本光电合作提升日本呼吸机产量japantimes.co.jp